We have a little bit before an IND number for the MIN science. Mind you, since preclinical trials have been moving along as anticipated (if not better), the FDA application for the MIN science could be submitted earlier than originally expected, I suppose. Who knows?
With regard to the first two, I think you very well might be on to something. And wouldn't that be just so very delightful?!?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.